Buckingham, United Kingdom–(ENEWSPF)–25 July 2013. The administration of the organic cannabinoid tetrahydrocannabivarin (THCV) is associated with positive metabolic effects that may potentially be beneficial to subjects with adult-onset diabetes, according to preclinical data published in the scientific journal Nutrition & Diabetes.
Investigators at the University of Buckingham in England and the Institute for Biomolecular Chemistry in Italy assessed the effects of THCV administration on dietary-induced and genetically modified obese mice. Authors reported that although THCV…
